Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
We CAN end hunger but only if we end conflict
November 2017. The vicious cycle of conflict and hunger must be broken if we are to achieve a world where everyone has enough to eat.
Children bear ‘disproportionate lethal impact’ of Syrian war, warns study
According to estimates, one in four civilians killed in 2016 was under the age of 18.
One million South Sudanese refugees in Uganda
08/09/2017. The civil war in South Sudan has taken its toll on neighboring country Uganda. The number of South Sudanese refugees in Uganda has now reached the million mark.
